Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Josh Schimmer's Stock Ratings
Cantor Fitzgerald Analyst
Josh Schimmer is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/19/2025
Overall Average Return
2.10%
Smart Score
Overall Average Return Percentile
41st
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 05/27/2025 | CMPS | Buy Now | Compass Pathways | $4.99 | 140.48% | Josh Schimmer56% | → $12 | Assumes | → Overweight | Get Alert |
| 05/16/2025 | SEPN | Buy Now | Septerna | $10.50 | 138.1% | Josh Schimmer56% | $20 → $25 | Maintains | Overweight | Get Alert |
| 05/16/2025 | RCKT | Buy Now | Rocket Pharmaceuticals | $2.83 | 960.07% | Josh Schimmer56% | $20 → $30 | Maintains | Overweight | Get Alert |
| 05/02/2025 | ASND | Buy Now | Ascendis Pharma | $170.71 | 64.02% | Josh Schimmer56% | $260 → $280 | Maintains | Outperform | Get Alert |
| 04/28/2025 | CGON | Buy Now | CG Oncology | $26.28 | 185.39% | Josh Schimmer56% | $75 → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 04/01/2025 | AARD | Buy Now | Aardvark Therapeutics | $12.08 | 313.91% | Josh Schimmer56% | $50 → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 03/25/2025 | ARTV | Buy Now | Artiva Biotherapeutics | $1.74 | 1049.69% | Josh Schimmer56% | $23 → $20 | Maintains | Overweight | Get Alert |
| 03/10/2025 | AARD | Buy Now | Aardvark Therapeutics | $12.08 | 313.91% | Josh Schimmer56% | → $50 | Initiates | → Overweight | Get Alert |
| 02/21/2025 | BBIO | Buy Now | BridgeBio Pharma | $39.99 | 137.56% | Josh Schimmer56% | $95 → $95 | Reiterates | Overweight → Overweight | Get Alert |
| 02/20/2025 | BBIO | Buy Now | BridgeBio Pharma | $39.99 | 137.56% | Josh Schimmer56% | $70 → $95 | Maintains | Overweight | Get Alert |
| 02/20/2025 | KRYS | Buy Now | Krystal Biotech | $132.09 | 62.77% | Josh Schimmer56% | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 02/18/2025 | ASND | Buy Now | Ascendis Pharma | $170.71 | 52.31% | Josh Schimmer56% | $220 → $260 | Maintains | Outperform | Get Alert |
| 02/11/2025 | SEPN | Buy Now | Septerna | $10.50 | 376.19% | Josh Schimmer56% | $50 → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 12/20/2024 | SPRO | Buy Now | Spero Therapeutics | $2.92 | 71.23% | Josh Schimmer56% | $5 → $5 | Downgrade | Outperform → In-Line | Get Alert |
| 12/11/2024 | JANX | Buy Now | Janux Therapeutics | $22.72 | 780.28% | Josh Schimmer56% | $200 → $200 | Reiterates | Overweight → Overweight | Get Alert |
| 12/11/2024 | TRML | Buy Now | Tourmaline Bio | $16.16 | 54.7% | Josh Schimmer56% | $25 → $25 | Reiterates | Overweight → Overweight | Get Alert |
| 12/11/2024 | ZURA | Buy Now | Zura Bio | $1.22 | — | Josh Schimmer56% | — | Reiterates | Overweight → Overweight | Get Alert |
| 11/19/2024 | RCKT | Buy Now | Rocket Pharmaceuticals | $2.83 | 2196.82% | Josh Schimmer56% | $65 → $65 | Reiterates | Overweight → Overweight | Get Alert |
| 11/19/2024 | SEPN | Buy Now | Septerna | $10.50 | 376.19% | Josh Schimmer56% | → $50 | Initiates | → Overweight | Get Alert |
| 11/07/2024 | JANX | Buy Now | Janux Therapeutics | $22.72 | 340.14% | Josh Schimmer56% | $100 → $100 | Reiterates | Overweight → Overweight | Get Alert |
| 10/18/2024 | ZURA | Buy Now | Zura Bio | $1.22 | — | Josh Schimmer56% | — | Reiterates | → Overweight | Get Alert |
| 10/14/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | Josh Schimmer56% | — | Downgrade | Overweight → Neutral | Get Alert |
| 10/08/2024 | SPRY | Buy Now | ARS Pharmaceuticals | $15.93 | 88.32% | Josh Schimmer56% | $30 → $30 | Reiterates | Overweight → Overweight | Get Alert |
| 09/23/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.09 | — | Josh Schimmer56% | — | Downgrade | Overweight → Neutral | Get Alert |
| 09/17/2024 | ALEC | Buy Now | Alector | $1.46 | — | Josh Schimmer56% | — | Reiterates | → Overweight | Get Alert |
| 09/17/2024 | ASND | Buy Now | Ascendis Pharma | $170.71 | 20.09% | Josh Schimmer56% | $191 → $205 | Maintains | Outperform | Get Alert |
| 09/16/2024 | SPRY | Buy Now | ARS Pharmaceuticals | $15.93 | 88.32% | Josh Schimmer56% | $30 → $30 | Reiterates | Overweight → Overweight | Get Alert |
| 09/16/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | Josh Schimmer56% | $90 → $90 | Reiterates | Overweight → Overweight | Get Alert |
| 09/16/2024 | JANX | Buy Now | Janux Therapeutics | $22.72 | 340.14% | Josh Schimmer56% | $100 → $100 | Reiterates | Overweight → Overweight | Get Alert |
| 09/16/2024 | CRNX | Buy Now | Crinetics Pharmaceuticals | $30.50 | 195.08% | Josh Schimmer56% | $90 → $90 | Reiterates | Overweight → Overweight | Get Alert |
| 09/16/2024 | BBIO | Buy Now | BridgeBio Pharma | $39.99 | 75.04% | Josh Schimmer56% | $70 → $70 | Reiterates | Overweight → Overweight | Get Alert |
| 09/09/2024 | JSPR | Buy Now | Jasper Therapeutics | $5.26 | — | Josh Schimmer56% | — | Reiterates | → Overweight | Get Alert |
| 09/09/2024 | INSM | Buy Now | Insmed | $98.60 | — | Josh Schimmer56% | — | Reiterates | → Overweight | Get Alert |
| 09/09/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.09 | — | Josh Schimmer56% | — | Reiterates | → Overweight | Get Alert |
| 09/09/2024 | ARWR | Buy Now | Arrowhead Pharma | $15.62 | — | Josh Schimmer56% | — | Reiterates | → Overweight | Get Alert |
| 09/09/2024 | ARCT | Buy Now | Arcturus Therapeutics | $12.35 | — | Josh Schimmer56% | — | Reiterates | → Overweight | Get Alert |
| 09/09/2024 | ANNX | Buy Now | Annexon | $2.36 | — | Josh Schimmer56% | — | Reiterates | → Overweight | Get Alert |
| 09/09/2024 | ALEC | Buy Now | Alector | $1.46 | — | Josh Schimmer56% | — | Reiterates | → Overweight | Get Alert |
| 09/09/2024 | ACLX | Buy Now | Arcellx | $63.82 | — | Josh Schimmer56% | — | Reiterates | → Overweight | Get Alert |
| 09/09/2024 | SPRY | Buy Now | ARS Pharmaceuticals | $15.93 | 88.32% | Josh Schimmer56% | $30 → $30 | Reiterates | Overweight → Overweight | Get Alert |
| 09/09/2024 | BBIO | Buy Now | BridgeBio Pharma | $39.99 | 75.04% | Josh Schimmer56% | $70 → $70 | Reiterates | Overweight → Overweight | Get Alert |
| 08/29/2024 | KRYS | Buy Now | Krystal Biotech | $132.09 | — | Josh Schimmer56% | — | Reiterates | → Overweight | Get Alert |
| 08/26/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | Josh Schimmer56% | $80 → $80 | Maintains | Outperform | Get Alert |
| 08/26/2024 | RLYB | Buy Now | Rallybio | $0.34 | 4370.94% | Josh Schimmer56% | $15 → $15 | Maintains | Outperform | Get Alert |
| 08/26/2024 | RNA | Buy Now | Avidity Biosciences | $28.89 | 83.45% | Josh Schimmer56% | $54 → $53 | Maintains | Outperform | Get Alert |
| 08/20/2024 | SPRY | Buy Now | ARS Pharmaceuticals | $15.93 | 88.32% | Josh Schimmer56% | → $30 | Initiates | → Overweight | Get Alert |
| 08/15/2024 | ZURA | Buy Now | Zura Bio | $1.22 | — | Josh Schimmer56% | — | Reiterates | → Overweight | Get Alert |
| 08/13/2024 | ARTV | Buy Now | Artiva Biotherapeutics | $1.74 | 1222.14% | Josh Schimmer56% | → $23 | Initiates | → Overweight | Get Alert |
| 08/12/2024 | RNA | Buy Now | Avidity Biosciences | $28.89 | 86.92% | Josh Schimmer56% | $45 → $54 | Maintains | Outperform | Get Alert |
| 08/09/2024 | XENE | Buy Now | Xenon Pharmaceuticals | $32.50 | 100% | Josh Schimmer56% | $65 → $65 | Reiterates | Overweight → Overweight | Get Alert |
| 08/08/2024 | JANX | Buy Now | Janux Therapeutics | $22.72 | 340.14% | Josh Schimmer56% | $100 → $100 | Reiterates | Overweight → Overweight | Get Alert |
| 08/08/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $50.80 | 18.11% | Josh Schimmer56% | $50 → $60 | Maintains | Overweight | Get Alert |
| 08/06/2024 | RCKT | Buy Now | Rocket Pharmaceuticals | $2.83 | 2196.82% | Josh Schimmer56% | $65 → $65 | Reiterates | Overweight → Overweight | Get Alert |
| 08/02/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | Josh Schimmer56% | $90 → $90 | Reiterates | Overweight → Overweight | Get Alert |
| 07/02/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | Josh Schimmer56% | $57 → $80 | Maintains | Outperform | Get Alert |
| 07/01/2024 | BBIO | Buy Now | BridgeBio Pharma | $39.99 | 75.04% | Josh Schimmer56% | $70 → $70 | Reiterates | Overweight → Overweight | Get Alert |
| 06/21/2024 | INSM | Buy Now | Insmed | $98.60 | -23.94% | Josh Schimmer56% | $42 → $75 | Maintains | Outperform | Get Alert |
| 06/21/2024 | CABA | Buy Now | Cabaletta Bio | $1.75 | 2757.14% | Josh Schimmer56% | $50 → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 06/20/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | Josh Schimmer56% | $44 → $57 | Maintains | Outperform | Get Alert |
| 06/20/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | Josh Schimmer56% | $60 → $60 | Reiterates | Overweight → Overweight | Get Alert |
| 06/17/2024 | ZURA | Buy Now | Zura Bio | $1.22 | — | Josh Schimmer56% | — | Reiterates | → Overweight | Get Alert |
| 06/12/2024 | RNA | Buy Now | Avidity Biosciences | $28.89 | 55.76% | Josh Schimmer56% | $40 → $45 | Maintains | Outperform | Get Alert |
| 06/12/2024 | ZURA | Buy Now | Zura Bio | $1.22 | — | Josh Schimmer56% | — | Initiates | → Overweight | Get Alert |
| 05/28/2024 | BBIO | Buy Now | BridgeBio Pharma | $39.99 | 75.04% | Josh Schimmer56% | $70 → $70 | Reiterates | Overweight → Overweight | Get Alert |
| 05/14/2024 | CRNX | Buy Now | Crinetics Pharmaceuticals | $30.50 | 113.11% | Josh Schimmer56% | $65 → $65 | Reiterates | Overweight → Overweight | Get Alert |
| 05/09/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $50.80 | -21.26% | Josh Schimmer56% | $40 → $40 | Reiterates | Overweight → Overweight | Get Alert |
| 05/09/2024 | JANX | Buy Now | Janux Therapeutics | $22.72 | 340.14% | Josh Schimmer56% | $100 → $100 | Reiterates | Overweight → Overweight | Get Alert |
| 05/06/2024 | CGON | Buy Now | CG Oncology | $26.28 | 185.39% | Josh Schimmer56% | $75 → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 05/03/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | Josh Schimmer56% | $60 → $60 | Reiterates | Overweight → Overweight | Get Alert |
| 05/02/2024 | CGON | Buy Now | CG Oncology | $26.28 | 185.39% | Josh Schimmer56% | $75 → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 04/10/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | Josh Schimmer56% | $60 → $60 | Reiterates | Overweight → Overweight | Get Alert |
| 04/10/2024 | XENE | Buy Now | Xenon Pharmaceuticals | $32.50 | 100% | Josh Schimmer56% | → $65 | Reiterates | Overweight → Overweight | Get Alert |
| 03/20/2024 | JANX | Buy Now | Janux Therapeutics | $22.72 | 340.14% | Josh Schimmer56% | → $100 | Initiates | → Overweight | Get Alert |
| 03/19/2024 | BBIO | Buy Now | BridgeBio Pharma | $39.99 | 75.04% | Josh Schimmer56% | $60 → $70 | Maintains | Overweight | Get Alert |
| 03/13/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | Josh Schimmer56% | $60 → $60 | Reiterates | Overweight → Overweight | Get Alert |
| 03/11/2024 | BBIO | Buy Now | BridgeBio Pharma | $39.99 | 50.04% | Josh Schimmer56% | $50 → $60 | Maintains | Overweight | Get Alert |
| 03/04/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $50.80 | -21.26% | Josh Schimmer56% | $35 → $40 | Maintains | Overweight | Get Alert |
| 03/04/2024 | CRNX | Buy Now | Crinetics Pharmaceuticals | $30.50 | 113.11% | Josh Schimmer56% | $50 → $65 | Maintains | Overweight | Get Alert |
| 02/29/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $50.80 | -31.1% | Josh Schimmer56% | $35 → $35 | Reiterates | Overweight → Overweight | Get Alert |
| 02/27/2024 | RCKT | Buy Now | Rocket Pharmaceuticals | $2.83 | 2196.82% | Josh Schimmer56% | $65 → $65 | Maintains | Overweight | Get Alert |
| 02/20/2024 | CGON | Buy Now | CG Oncology | $26.28 | 185.39% | Josh Schimmer56% | → $75 | Initiates | → Overweight | Get Alert |
| 02/02/2024 | CRNX | Buy Now | Crinetics Pharmaceuticals | $30.50 | 63.93% | Josh Schimmer56% | $50 → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 01/22/2024 | BBIO | Buy Now | BridgeBio Pharma | $39.99 | 25.03% | Josh Schimmer56% | $50 → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 01/16/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | Josh Schimmer56% | $55 → $60 | Maintains | Overweight | Get Alert |
| 01/02/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | Josh Schimmer56% | $35 → $55 | Maintains | Overweight | Get Alert |
| 12/21/2023 | RLYB | Buy Now | Rallybio | $0.34 | 4370.94% | Josh Schimmer56% | $18 → $15 | Maintains | Outperform | Get Alert |
| 12/20/2023 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | Josh Schimmer56% | $35 → $35 | Reiterates | Overweight → Overweight | Get Alert |
| 12/19/2023 | CRNX | Buy Now | Crinetics Pharmaceuticals | $30.50 | 63.93% | Josh Schimmer56% | $50 → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 12/19/2023 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | Josh Schimmer56% | $35 → $35 | Reiterates | Overweight → Overweight | Get Alert |
| 12/13/2023 | KRYS | Buy Now | Krystal Biotech | $132.09 | 36.27% | Josh Schimmer56% | $160 → $180 | Maintains | Overweight | Get Alert |
| 12/04/2023 | CRNX | Buy Now | Crinetics Pharmaceuticals | $30.50 | 63.93% | Josh Schimmer56% | → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 11/27/2023 | MIRM | Buy Now | Mirum Pharmaceuticals | $50.80 | -1.57% | Josh Schimmer56% | → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 11/10/2023 | VTYX | Buy Now | Ventyx Biosciences | $2.42 | 106.61% | Josh Schimmer56% | $43 → $5 | Downgrade | Outperform → In-Line | Get Alert |
| 11/07/2023 | KRYS | Buy Now | Krystal Biotech | $132.09 | 21.13% | Josh Schimmer56% | → $160 | Reiterates | Overweight → Overweight | Get Alert |
| 10/24/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.09 | 682.4% | Josh Schimmer56% | → $32 | Initiates | → Overweight | Get Alert |
| 10/24/2023 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | Josh Schimmer56% | $16 → $35 | Assumes | → Overweight | Get Alert |
| 10/24/2023 | XENE | Buy Now | Xenon Pharmaceuticals | $32.50 | — | Josh Schimmer56% | — | Assumes | → Overweight | Get Alert |
| 10/24/2023 | RCKT | Buy Now | Rocket Pharmaceuticals | $2.83 | 2196.82% | Josh Schimmer56% | → $65 | Initiates | → Overweight | Get Alert |
| 10/24/2023 | BBIO | Buy Now | BridgeBio Pharma | $39.99 | 25.03% | Josh Schimmer56% | → $50 | Initiates | → Overweight | Get Alert |
| 10/24/2023 | KRYS | Buy Now | Krystal Biotech | $132.09 | 21.13% | Josh Schimmer56% | → $160 | Initiates | → Overweight | Get Alert |
| 09/07/2023 | INSM | Buy Now | Insmed | $98.60 | -57.4% | Josh Schimmer56% | $32 → $42 | Maintains | Outperform | Get Alert |
| 06/14/2023 | KDNY | Buy Now | Chinook Therapeutics | — | — | Josh Schimmer56% | → $40 | Downgrade | Outperform → In-Line | Get Alert |
| 06/06/2023 | ERAS | Buy Now | Erasca | $1.40 | 685.71% | Josh Schimmer56% | $20 → $11 | Maintains | Outperform | Get Alert |
| 05/22/2023 | RNA | Buy Now | Avidity Biosciences | $28.89 | -30.77% | Josh Schimmer56% | → $20 | Upgrade | In-Line → Outperform | Get Alert |
| 04/19/2023 | BBIO | Buy Now | BridgeBio Pharma | $39.99 | 0.03% | Josh Schimmer56% | → $40 | Initiates | → Outperform | Get Alert |
| 04/18/2023 | BLU | Buy Now | BELLUS Health | — | — | Josh Schimmer56% | $24 → $14.75 | Downgrade | Outperform → In-Line | Get Alert |
| 03/30/2023 | BCEL | Buy Now | Atreca | — | — | Josh Schimmer56% | $2 → $1.5 | Downgrade | Outperform → In-Line | Get Alert |
| 11/14/2022 | NBIX | Buy Now | Neurocrine Biosciences | $127.31 | 2.11% | Josh Schimmer56% | $140 → $130 | Downgrade | Outperform → In-Line | Get Alert |
| 10/17/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | 47.98% | Josh Schimmer56% | → $760 | Downgrade | Outperform → In-Line | Get Alert |
| 09/23/2022 | SPRO | Buy Now | Spero Therapeutics | $2.92 | 173.96% | Josh Schimmer56% | $2 → $8 | Upgrade | In-Line → Outperform | Get Alert |
| 05/04/2022 | SPRO | Buy Now | Spero Therapeutics | $2.92 | -31.51% | Josh Schimmer56% | $40 → $2 | Downgrade | Outperform → In-Line | Get Alert |
| 03/15/2022 | ZYME | Buy Now | Zymeworks | $12.63 | 18.76% | Josh Schimmer56% | → $15 | Initiates | → Outperform | Get Alert |
| 12/13/2021 | BLU | Buy Now | BELLUS Health | — | — | Josh Schimmer56% | $12 → $20 | Maintains | Outperform | Get Alert |
| 11/15/2021 | VTYX | Buy Now | Ventyx Biosciences | $2.42 | 1966.12% | Josh Schimmer56% | → $50 | Initiates | → Outperform | Get Alert |
| 09/07/2021 | RNA | Buy Now | Avidity Biosciences | $28.89 | 73.07% | Josh Schimmer56% | → $50 | Initiates | → Outperform | Get Alert |
| 08/23/2021 | RLYB | Buy Now | Rallybio | $0.34 | 11822.5% | Josh Schimmer56% | → $40 | Initiates | → Outperform | Get Alert |
| 08/23/2021 | ICVX | Buy Now | Icosavax | — | — | Josh Schimmer56% | → $50 | Initiates | → Outperform | Get Alert |
| 08/10/2021 | ERAS | Buy Now | Erasca | $1.40 | 3114.29% | Josh Schimmer56% | → $45 | Initiates | → Outperform | Get Alert |
| 06/01/2021 | TALS | Buy Now | Talaris Therapeutics | — | — | Josh Schimmer56% | → $35 | Initiates | → Outperform | Get Alert |
| 04/07/2021 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | Josh Schimmer56% | → $35 | Initiates | → Outperform | Get Alert |
| 03/25/2021 | VIRX | Buy Now | Viracta Therapeutics | $0.02 | 267757.14% | Josh Schimmer56% | → $45 | Initiates | → Outperform | Get Alert |
| 02/02/2021 | CGEM | Buy Now | Cullinan Oncology | $8.16 | 574.02% | Josh Schimmer56% | → $55 | Initiates | → Outperform | Get Alert |
| 12/29/2020 | BYSI | Buy Now | BeyondSpring | $2.67 | 1023.6% | Josh Schimmer56% | → $30 | Initiates | → Outperform | Get Alert |
| 11/24/2020 | INSM | Buy Now | Insmed | $98.60 | -39.15% | Josh Schimmer56% | → $60 | Reinstates | → Outperform | Get Alert |
| 11/18/2020 | BLU | Buy Now | BELLUS Health | — | — | Josh Schimmer56% | → $12 | Initiates | → Outperform | Get Alert |
| 09/29/2020 | SPRO | Buy Now | Spero Therapeutics | $2.92 | 2297.18% | Josh Schimmer56% | → $70 | Initiates | → Outperform | Get Alert |
| 09/01/2020 | FRLN | Buy Now | Freeline Therapeutics | — | — | Josh Schimmer56% | → $32 | Initiates | → Outperform | Get Alert |
| 05/12/2020 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Josh Schimmer56% | → $15 | Upgrade | In-Line → Outperform | Get Alert |
| 12/09/2019 | BOLD | Buy Now | Audentes Therapeutics | $1.04 | — | Josh Schimmer56% | — | Downgrade | Outperform → In-Line | Get Alert |
| 11/25/2019 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Josh Schimmer56% | — | Downgrade | Outperform → In-Line | Get Alert |
| 11/19/2019 | BOLD | Buy Now | Audentes Therapeutics | $1.04 | 3746.15% | Josh Schimmer56% | → $40 | Upgrade | In-Line → Outperform | Get Alert |
| 04/12/2019 | MYOV | Buy Now | Myovant Sciences | — | — | Josh Schimmer56% | — | Initiates | → Outperform | Get Alert |
| 02/25/2019 | RGNX | Buy Now | Regenxbio | $8.55 | — | Josh Schimmer56% | — | Upgrade | In-Line → Outperform | Get Alert |
| 11/16/2018 | MDGL | Buy Now | Madrigal Pharmaceuticals | $282.72 | -11.57% | Josh Schimmer56% | $222 → $250 | Upgrade | In-Line → Outperform | Get Alert |
| 09/04/2018 | SHPG | Buy Now | Shire | — | — | Josh Schimmer56% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 06/19/2018 | MDGL | Buy Now | Madrigal Pharmaceuticals | $282.72 | — | Josh Schimmer56% | — | Downgrade | Outperform → In-Line | Get Alert |
| 06/19/2018 | BLUE | Buy Now | bluebird bio | — | — | Josh Schimmer56% | $175 → $230 | Upgrade | In-Line → Outperform | Get Alert |
| 06/11/2018 | INCY | Buy Now | Incyte | $68.23 | — | Josh Schimmer56% | — | Upgrade | → Outperform | Get Alert |
| 05/08/2018 | IONS | Buy Now | Ionis Pharmaceuticals | $37.02 | — | Josh Schimmer56% | — | Downgrade | Outperform → In-Line | Get Alert |
| 03/12/2018 | VYGR | Buy Now | Voyager Therapeutics | $3.10 | — | Josh Schimmer56% | — | Downgrade | Outperform → In-Line | Get Alert |
| 03/12/2018 | RGNX | Buy Now | Regenxbio | $8.55 | — | Josh Schimmer56% | — | Downgrade | Outperform → In-Line | Get Alert |
| 03/12/2018 | DNLI | Buy Now | Denali Therapeutics | $14.09 | — | Josh Schimmer56% | — | Downgrade | Outperform → In-Line | Get Alert |
| 02/13/2018 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Josh Schimmer56% | — | Initiates | → Outperform | Get Alert |
| 02/08/2018 | MDGL | Buy Now | Madrigal Pharmaceuticals | $282.72 | -38.1% | Josh Schimmer56% | $140 → $175 | Maintains | Outperform | Get Alert |
| 01/02/2018 | DNLI | Buy Now | Denali Therapeutics | $14.09 | 63.24% | Josh Schimmer56% | → $23 | Initiates | → Outperform | Get Alert |
| 11/07/2017 | QURE | Buy Now | uniQure | $14.50 | 51.72% | Josh Schimmer56% | → $22 | Initiates | → Outperform | Get Alert |
| 11/06/2017 | BLUE | Buy Now | bluebird bio | — | — | Josh Schimmer56% | — | Downgrade | Outperform → In-Line | Get Alert |
| 10/30/2017 | ADMS | Buy Now | Adamas Pharmaceuticals | — | — | Josh Schimmer56% | → $85 | Initiates | → Outperform | Get Alert |
| 10/16/2017 | BLUE | Buy Now | bluebird bio | — | — | Josh Schimmer56% | — | Upgrade | In-Line → Outperform | Get Alert |
| 10/16/2017 | BOLD | Buy Now | Audentes Therapeutics | $1.04 | — | Josh Schimmer56% | — | Downgrade | Outperform → In-Line | Get Alert |
| 09/22/2017 | MDGL | Buy Now | Madrigal Pharmaceuticals | $282.72 | -77.01% | Josh Schimmer56% | → $65 | Initiates | → Outperform | Get Alert |
| 08/17/2017 | ONCE | Buy Now | Spark Therapeutics | — | — | Josh Schimmer56% | → $83 | Initiates | → In-Line | Get Alert |
| 08/17/2017 | INCY | Buy Now | Incyte | $68.23 | 97.85% | Josh Schimmer56% | → $135 | Initiates | → In-Line | Get Alert |
| 08/17/2017 | VYGR | Buy Now | Voyager Therapeutics | $3.10 | 577.42% | Josh Schimmer56% | → $21 | Initiates | → Outperform | Get Alert |
| 08/17/2017 | TBPH | Buy Now | Theravance Biopharma | $10.62 | — | Josh Schimmer56% | — | Initiates | → Outperform | Get Alert |
| 08/17/2017 | SHPG | Buy Now | Shire plc - American Depositary Shares, each representing three Ordinary Shares | — | — | Josh Schimmer56% | → $196 | Initiates | → Outperform | Get Alert |
| 08/17/2017 | RGNX | Buy Now | Regenxbio | $8.55 | 192.4% | Josh Schimmer56% | → $25 | Initiates | → Outperform | Get Alert |
| 08/17/2017 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | 17.8% | Josh Schimmer56% | → $605 | Initiates | → Outperform | Get Alert |
| 08/17/2017 | MYOV | Buy Now | Myovant Sciences | — | — | Josh Schimmer56% | → $35 | Initiates | → Outperform | Get Alert |
| 08/17/2017 | IONS | Buy Now | Ionis Pharmaceuticals | $37.02 | 75.58% | Josh Schimmer56% | → $65 | Initiates | → Outperform | Get Alert |
| 08/17/2017 | INSM | Buy Now | Insmed | $98.60 | -71.6% | Josh Schimmer56% | → $28 | Initiates | → Outperform | Get Alert |
| 08/17/2017 | BOLD | Buy Now | Audentes Therapeutics | $1.04 | 2111.54% | Josh Schimmer56% | → $23 | Initiates | → Outperform | Get Alert |
| 08/17/2017 | BMRN | Buy Now | Biomarin Pharmaceutical | $55.28 | — | Josh Schimmer56% | — | Initiates | → Outperform | Get Alert |
| 08/17/2017 | AVXS | Buy Now | AveXis | — | — | Josh Schimmer56% | → $120 | Initiates | → Outperform | Get Alert |
| 08/17/2017 | ABBV | Buy Now | AbbVie | $185.00 | -48.65% | Josh Schimmer56% | → $95 | Initiates | → Outperform | Get Alert |
| 08/17/2017 | BLUE | Buy Now | bluebird bio | — | — | Josh Schimmer56% | → $102 | Initiates | → In-Line | Get Alert |
| 08/29/2016 | TBPH | Buy Now | Theravance Biopharma | $10.62 | 286.06% | Josh Schimmer56% | → $41 | Initiates | → Buy | Get Alert |
| 04/12/2016 | ONCE | Buy Now | Spark Therapeutics | — | — | Josh Schimmer56% | → $37 | Initiates | → Buy | Get Alert |
